Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 19Unknown 6Recruiting 5Terminated 3Active not recruiting 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Breast 1

Conditions

Stomach Neoplasms 1Neoplasms 1Esophageal Neoplasms 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Fish Oils × Clear all
NCT01325584 2018-08-07

Compassionate Use of OmegavenĀ® in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Midwestern Regional Medical Center

Phase 2 Terminated
12 enrolled 10 charts
Tumor-Agnostic

Neoplasms

NCT01870791 2016-05-26

Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer

University Hospitals, Leicester

Phase 2 Terminated
21 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT01548534 2015-07-29

DHALYA

University Hospital, Tours

Phase 3 Terminated
65 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔